Cargando…
DMF-Activated Nrf2 Ameliorates Palmitic Acid Toxicity While Potentiates Ferroptosis Mediated Cell Death: Protective Role of the NO-Donor S-Nitroso-N-Acetylcysteine
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that can develop into an aggressive form called nonalcoholic steatohepatitis (NASH), which ultimately progresses to cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver failure. Currently, the deterioratio...
Autores principales: | Abu-Halaka, Diana, Shpaizer, Adi, Zeigerman, Haim, Kanner, Joseph, Tirosh, Oren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952671/ https://www.ncbi.nlm.nih.gov/pubmed/36830070 http://dx.doi.org/10.3390/antiox12020512 |
Ejemplares similares
-
Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH
por: Rauchbach, Einat, et al.
Publicado: (2022) -
Redox homeostasis in stomach medium by foods: The Postprandial Oxidative Stress Index (POSI) for balancing nutrition and human health
por: Kanner, Joseph, et al.
Publicado: (2017) -
S-Nitroso-N-Acetylcysteine Ameliorates Ischemia-Reperfusion Injury In The Steatotic Liver
por: Andraus, Wellington, et al.
Publicado: (2010) -
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
por: Mazo, Daniel FC, et al.
Publicado: (2013) -
S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic
steatohepatitis [Corrigendum]
Publicado: (2013)